For patients with stage III or IV high grade serous ovarian carcinomas treated with adjuvant post-operative carboplatin – paclitaxel regimen (every 3 weeks or weekly) in first-line setting, after primary cytoreductive surgery.
This model does not apply in patients treated in recurrent setting.
CA-125 KELIM™ is calculated with at least 3 CA-125 values measured within the first 100 days (or less) after chemotherapy start.
For scientific studies ≥ 2 patients, the website team should be contacted at biomarkers.kinetics@univ-lyon1.fr